(2R,3R,4S)-3-acetamido-4-(3-(2-(naphthalen-1-ylthio)acetyl)guanidino)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid

ID: ALA3355596

Chembl Id: CHEMBL3355596

PubChem CID: 118720939

Max Phase: Preclinical

Molecular Formula: C24H28N4O8S

Molecular Weight: 532.58

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1NC(=N)NC(=O)CSc1cccc2ccccc12

Standard InChI:  InChI=1S/C24H28N4O8S/c1-12(30)26-20-15(9-17(23(34)35)36-22(20)21(33)16(31)10-29)27-24(25)28-19(32)11-37-18-8-4-6-13-5-2-3-7-14(13)18/h2-9,15-16,20-22,29,31,33H,10-11H2,1H3,(H,26,30)(H,34,35)(H3,25,27,28,32)/t15-,16+,20+,21+,22+/m0/s1

Standard InChI Key:  UVRXMGICDWZBSS-NTZWLTRZSA-N

Alternative Forms

  1. Parent:

    ALA3355596

    ---

Associated Targets(non-human)

NA Neuraminidase (126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NA Neuraminidase (1107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 532.58Molecular Weight (Monoisotopic): 532.1628AlogP: -0.47#Rotatable Bonds: 9
Polar Surface Area: 201.30Molecular Species: ZWITTERIONHBA: 9HBD: 8
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.25CX Basic pKa: 8.76CX LogP: -2.86CX LogD: -2.88
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.12Np Likeness Score: 0.18

References

1. Xie Y, Xu D, Huang B, Ma X, Qi W, Shi F, Liu X, Zhang Y, Xu W..  (2014)  Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.,  57  (20): [PMID:25255388] [10.1021/jm500892k]
2. Wang K, Lei Z, Zhao L, Chen B, Yang F, Liu K, Zhu H, Zhao H, Cao R, Zhang K, Tian Y..  (2020)  Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A.,  185  [PMID:31708183] [10.1016/j.ejmech.2019.111841]

Source